Top Markets
Coin of the day
Boston Scientific Corporation Boston Scientific Corporation

Boston Scientific Corporation

BSX
Rank in Stocks #210
Boston Scientific Corporation develops, manufactures, and markets medical... Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Share Price
$62.83
Market Cap
$93.23B
Change (1 day)
-9.17%
Change (1 year)
-31.36%
Country
US
Trade Boston Scientific Corporation (BSX)

Category

Operating Margin for Boston Scientific Corporation (BSX)
Operating Margin as of April 2026 TTM: 19.78%
According to Boston Scientific Corporation latest financial reports and stock price the company's current Operating Margin (TTM) is 19.78%. At the end of 2024 the company had an Operating Margin of 15.73%.
Operating Margin history for Boston Scientific Corporation from 2000 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) 19.78% 0.00%
2025 19.78% 25.75%
2024 15.73% 2.68%
2023 15.32% 6.54%
2022 14.38% -11.07%
2021 16.17% 166.83%
2020 6.06% -62.01%
2019 15.95% -9.79%
2018 17.68% 4.93%
2017 16.85% 14.31%
2016 14.74% 39.45%
2015 10.57% -7.69%
2014 11.45% -6.07%
2013 12.19% -11.09%
2012 13.71% -6.92%
2011 14.73% 7.13%
2010 13.75% -13.58%
2009 15.91% -1.12%
2008 16.09% 13.95%
2007 14.12% -10.58%
2006 15.79% -50.98%
2005 32.21% 2.29%
2004 31.49% 57.06%
2003 20.05% -4.07%
2002 20.90% 458.82%
2001 3.74% -85.24%
2000 25.34% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
18.16% -99.08%
US
22.44% -98.87%
US
17.86% -99.10%
IE
17.86% -99.10%
IE
14.72% -99.26%
DE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.